Davide Trotti (@davidetrotti1) 's Twitter Profile
Davide Trotti

@davidetrotti1

Dad, husband, neuroscientist, ALS researcher, citizen.

ID: 743008518

calendar_today07-08-2012 14:26:07

402 Tweet

171 Takipçi

149 Takip Edilen

Davide Trotti (@davidetrotti1) 's Twitter Profile Photo

Congrats to Hristelina! Increased synthesis of pro-inflammatory cytokines in C9ORF72 patients tandfonline.com/doi/full/10.10…

Davide Trotti (@davidetrotti1) 's Twitter Profile Photo

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis pubmed.ncbi.nlm.nih.gov/34338673/ Nice Job Karthik & Brigid

Jefferson Research (@researchatjeff) 's Twitter Profile Photo

New #JeffersonResearch from @haeuslerlab finds that a crowded molecular environment can influence the DNA structures formed by mutations in the C9orf72 gene. The study provides new drug targets to treat neurodegenerative diseases like ALS that are linked to the C9orf72 mutation.

New #JeffersonResearch from @haeuslerlab finds that a crowded molecular environment can influence the DNA structures formed by mutations in the C9orf72 gene. The study provides new drug targets to treat neurodegenerative diseases like ALS that are linked to the C9orf72 mutation.
Davide Trotti (@davidetrotti1) 's Twitter Profile Photo

Biogen and Ionis Announce Topline Phase 1 Study Results of Investigational Drug in C9orf72 Amyotrophic Lateral Sclerosis | BioSpace biospace.com/article/releas… #jobs

Davide Trotti (@davidetrotti1) 's Twitter Profile Photo

Targeting TNFα produced by astrocytes expressing amyotrophic lateral sclerosis‐linked mutant fused in sarcoma prevents neurodegeneration and motor dysfunction in mice onlinelibrary.wiley.com/doi/10.1002/gl… Nice work Brigid and Weinberg ALS Center

Target ALS (@targetals_fdn) 's Twitter Profile Photo

Don’t miss the Founder of Target ALS, Dan Doctoroff, addressing our partners in the ALS research community at our 2022 Annual Meeting. Watch now: bit.ly/3LFM75I #ALSResearch #ALSAwarenessMonth #EndALS #TheWorkContinues #EndALS

Don’t miss the Founder of Target ALS, Dan Doctoroff, addressing our partners in the ALS research community at our 2022 Annual Meeting. Watch now: bit.ly/3LFM75I
 
#ALSResearch #ALSAwarenessMonth #EndALS #TheWorkContinues #EndALS
Davide Trotti (@davidetrotti1) 's Twitter Profile Photo

Ionis partner Biogen announces that results from Phase 3 VALOR study and open-label extension of tofersen showed c... prn.to/3GKHJ3L

Dan Rather (@danrather) 's Twitter Profile Photo

I remember the anticipation over “Who shot J.R.?” It’s like tomorrow’s surprise witness at the January 6 hearings: “Who sabotaged American democracy?” (I mean we already know, but still, get the popcorn ready!)

Andy Slavitt 🇺🇦 (@aslavitt) 's Twitter Profile Photo

I don’t know if a half-dozen people have ever done more damage to the planet, to human welfare, to democracy, and to public safety in the course of less than a year.

Davide Trotti (@davidetrotti1) 's Twitter Profile Photo

Altered Bioenergetics and Metabolic Homeostasis in Amyotrophic Lateral Sclerosis. Nice work Andrew. readcube.com/articles/10.10…

Davide Trotti (@davidetrotti1) 's Twitter Profile Photo

Kulicke & Soffa Supports MGH and Jefferson Health to Increase ALS Patient Access to Potentially Life-Saving Advanc... prn.to/3RaO390 Job Well Done, Weinberg ALS Center!

Davide Trotti (@davidetrotti1) 's Twitter Profile Photo

Breakdown of the central synapses in C9orf72-linked ALS/FTD frontiersin.org/articles/10.33… A nice review from Layla, Brigid, and Co.